Skip to main content
. 2020 Jun 26;38(31):4877–4884. doi: 10.1016/j.vaccine.2020.04.066

Table 1.

Characteristics of trial participants.

Vaccinated Non-vaccinated
Participants 1172 99
Age (years) 34.5 (11.10) 28.31 (7.04)
Female 312 (26.62) 37 (37.37)
Male 860 (73.38) 62 (62.63)
Workplace
Ebola Treatment Center 173 (14.76) 0 (0)
Ebola outreach services 219 (18.69) 19 (19.19)
Hospital 445 (37.97) 11 (11.11)
Health Centre 251 (21.42) 64 (64.65)
Clinic 6 (0.51) 0 (0)
Other 78 (6.66) 5 (5.05)
Risk category
High-risk 609 (51.96) 68 (68.69)
Low-risk 563 (48.04) 31 (31.31)

*Data are means (SD) or numbers (%).